EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The PMA phorbol ester tumor promoter increases canonical Wnt signaling via macropinocytosis

Nydia Tejeda-Munoz, Yagmur Azbazdar, Julia Monka, Grace Binder, Alex Dayrit, Raul Ayala, Neil O'Brien, Edward M De Robertis iD

eLife · 2023

DOI: 10.7554/elife.89141 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, 2023. Verfasst von Nydia Tejeda-Munoz und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Chemistry, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, United States. Hauptthemen laut MEDLINE: Carcinogens, Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, Cancer Research Coordinating Committee.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Activation of the Wnt pathway lies at the core of many human cancers. Wnt and macropinocytosis are often active in the same processes, and understanding how Wnt signaling and membrane trafficking cooperate should improve our understanding of embryonic development and cancer. Here, we show that a macropinocytosis activator, the tumor promoter phorbol 12-myristate 13-acetate (PMA), enhances Wnt signaling. Experiments using the Xenopus embryo as an in vivo model showed marked cooperation between the PMA phorbol ester and Wnt signaling, which was blocked by inhibitors of macropinocytosis, Rac1 activity, and lysosome acidification. Human colorectal cancer tissue arrays and xenografts in mice showed a correlation of cancer progression with increased macropinocytosis/multivesicular body/lysosome markers and decreased GSK3 levels. The crosstalk between canonical Wnt, focal adhesions, lysosomes, and macropinocytosis suggests possible therapeutic targets for cancer progression in Wnt-driven cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CarcinogensNeoplasmsFemalePregnancyHumansAnimalsMiceWnt Signaling PathwayGlycogen Synthase Kinase 3Phorbol EstersEsters

Stichwörter der Autor:innen

Wnt signalingcancer biologycolorectal cancerdevelopmental biologylysosomesmacropinocytosisxenopusβ-catenin

Substanzen

CarcinogensGlycogen Synthase Kinase 3Phorbol EstersEsters

Autor:innen und Institutionen

  • Department of Biological Chemistry, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, United States.
  • Department of Oncology Science, Health Stephenson Cancer Center, University of Oklahoma Health Science Center, Oklahoma City, United States.
  • Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, United States.

ORCID-Profile: Edward M De Robertis

Förderung

  • NCI NIH HHS
  • NIH HHS
  • Cancer Research Coordinating Committee
  • National Institutes of Health
  • Sprague Endowment for Molecular Oncology, University of California, Los Angeles

Zitieren

APA

Tejeda-Munoz, N., Azbazdar, Y., Monka, J., Binder, G., Dayrit, A., Ayala, R., O'Brien, N., & De Robertis, E. M. (2023). The PMA phorbol ester tumor promoter increases canonical Wnt signaling via macropinocytosis. eLife. https://doi.org/10.7554/elife.89141

Vancouver

Tejeda-Munoz N, Azbazdar Y, Monka J, Binder G, Dayrit A, Ayala R, et al. The PMA phorbol ester tumor promoter increases canonical Wnt signaling via macropinocytosis. eLife. 2023. doi:10.7554/elife.89141

BibTeX
@article{TejedaMunoz2023,
  author = {Tejeda-Munoz, Nydia and Azbazdar, Yagmur and Monka, Julia and Binder, Grace and Dayrit, Alex and Ayala, Raul and O'Brien, Neil and De Robertis, Edward M},
  title = {The PMA phorbol ester tumor promoter increases canonical Wnt signaling via macropinocytosis},
  journal = {eLife},
  year = {2023},
  doi = {10.7554/elife.89141}
}
Kostenlos starten →